 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JERUSALEM, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX, Entera ) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (NASDAQ: OPK, OPKO ) have entered into a Research...

Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes

JERUSALEM, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (Entera or the Company) a leader in the development of orally delivered peptides and therapeutic proteins, today announced that it has been selected to present data for its investigational agent EB613 at the ASBMR 2023 ...

Entera Bio to Present Two Abstracts on its First-in-Class, Once Daily Oral hPTH(1-34) Peptide Tablets (EB613) for the Treatment of Post-Menopausal Women at High Risk of Fracture at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting

JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (Entera or the Company) a leader in the development of orally delivered peptides and therapeutic proteins, today reported corporate updates and financial results for the second quarter endedJune 30, 2023. In the last year, ...

Entera Bio Announces Q2 2023 Financial Results and Corporate Updates

JERUSALEM, June 07, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (Entera or the Company) a leader in the development of orally delivered peptides and therapeutic proteins, today announced that it has appointed Haya Taitel, Head of Sanofis Global Transplant Franchise as an independent ...

Entera Bio Adds Sanofi Commercial Leader, Haya Taitel to its Board of Directors

Codiak BioSciences (NASDAQ:CDAK Get Rating) and Entera Bio (NASDAQ:ENTX Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and ...

Contrasting Entera Bio (NASDAQ:ENTX) & Codiak BioSciences (NASDAQ:CDAK)

Codiak BioSciences (NASDAQ:CDAK  Get Rating) and Entera Bio (NASDAQ:ENTX  Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, ...

Financial Review: Entera Bio (NASDAQ:ENTX) versus Codiak BioSciences (NASDAQ:CDAK)

Entera Bio Ltd. (NASDAQ:ENTX  Get Rating)  Equities researchers at HC Wainwright lifted their Q2 2023 EPS estimates for Entera Bio in a note issued to investors on Monday, May 8th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.07...

Entera Bio Ltd. to Post Q2 2023 Earnings of ($0.07) Per Share, HC Wainwright Forecasts (NASDAQ:ENTX)

Entera Bio Ltd. (NASDAQ:ENTX Get Rating) Equities researchers at HC Wainwright lifted their Q2 2023 EPS estimates for Entera Bio in a note issued to investors on Monday, May 8th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.07) for the quarter...

Entera Bio: Q1 Earnings Insights

JERUSALEM, May 05, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (Entera or the Company) a leader in the development of orally delivered peptides and therapeutic proteins, today reported corporate updates and financial results for the first quarter endedMarch 31, 2023. Our primary ...

Entera Bio Announces Q1 2023 Financial Results and Corporate Updates

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.

Watchers	7,352
52-Wk Low	$0.4722
52-Wk High	$1.48

Market Cap	$20.46M
Volume (M)	270.00
52-Wk High	$1.48
52-Wk Low	$0.4722

ENTX Entera Bio Ltd

About

Feed

News

Sentiment

Fundamentals